Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial
Rick Admiraal, Stefan Nierkens, Marc Bierings, Robbert G. M. Bredius, Ineke van Vliet, Yilin Jiang, Marta López‐Yurda, A. Birgitta Versluijs, C. Michel Zwaan, Caroline A. Lindemans, Jaap Jan Boelens
Topics & Concepts
Anti-thymocyte globulinMedicineTransplantationDosingHematopoietic stem cell transplantationInternal medicineClinical endpointGraft-versus-host diseaseAdverse effectImmunologySurgeryClinical trialHematopoietic Stem Cell TransplantationImmunodeficiency and Autoimmune DisordersCAR-T cell therapy research